Emerging drugs for epilepsy (Q34688725)

3 August 2017

1 reference

title

Emerging drugs for epilepsy (English)

1 reference

3 August 2017

2

Martin J Brodie

0 references

Patrick Kwan

object named as

Patrick Kwan

series ordinal

1

0 references

author name string

Martin J Brodie

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Emerging Drugs

3 August 2017

published in

1 reference

3 August 2017

volume

12

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

407-422

1 reference

Epidemiology of the epilepsies

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The natural history of epilepsy: an epidemiological view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

On the cellular and network bases of epileptic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The neurobiology of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Channelopathies as a genetic cause of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Life expectancy in people with newly diagnosed epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Comprehensive care of the epilepsy patient--control, comorbidity, and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The cost of epilepsy in the United States: an estimate from population-based clinical and survey data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Combination therapy in epilepsy: when and what to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Phenobarbital for the treatment of epilepsy in the 21st century: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Diagnosing refractory epilepsy: response to sequential treatment schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Measuring the efficacy of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Life-threatening adverse events of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Increased rate of major malformations in offspring exposed to valproate during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Antiepileptic drug use of women with epilepsy and congenital malformations in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

In utero antiepileptic drug exposure: fetal death and malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The mechanisms of action of commonly used antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Discovery of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Diverse mechanisms of antiepileptic drugs in the development pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Antiepileptic drugs in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

Brivaracetam (UCB 34714)

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Development of amygdaloid kindling in histidine decarboxylase-deficient and histamine H1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Novel anticonvulsant drugs targeting voltage-dependent ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Eslicarbazepine acetate (BIA 2-093).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Valproic Acid: second generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

A potassium channel mutation in neonatal human epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Non-competitive AMPA antagonists of 2,3-benzodiazepine type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

A crossover, add-on trial of talampanel in patients with refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Pharmacology of endogenous neuroactive steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Seeking a mechanism of action for the novel anticonvulsant lacosamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Rufinamide: Pharmacology, clinical trials, and role in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Refractory epilepsy: mechanisms and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Molecular targets for antiepileptic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Potential new methods for antiepileptic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.12.3.407

10.1517/14728214.12.3.407

21 January 2018

Identifiers

DOI

1 reference

release_c6jvcnblvjhwvcbuie5ryquphi

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c6jvcnblvjhwvcbuie5ryquphi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference